Description
What is PT-141?
PT-141 — bremelanotide in the clinical literature — is a cyclic melanocortin agonist that emerged as a metabolite of Melanotan II. Where most compounds in its research space act on vascular tissue, PT-141 works centrally: it activates MC3R/MC4R circuits in the hypothalamus, engaging arousal pathways in the brain rather than the periphery. That central mechanism is precisely what makes it scientifically interesting.
Bremelanotide ultimately reached FDA approval (Vyleesi) in the clinical world, which gives PT-141 one of the deepest published datasets of any peptide in this catalogue — pharmacokinetics, receptor selectivity, and dose-response are all well characterized in the open literature.
| Contents | 10 × 10mg vials of PT-141 (bremelanotide) |
|---|---|
| Form | Lyophilized powder, sterile sealed vial |
| Purity | ≥99% (HPLC verified) |
| Batch | All 10 vials from one production lot |
| Certificate | Third-party COA per batch (request with your batch number) |
| Storage | Sealed: refrigerate 2–8°C; reconstituted: refrigerate and use within recommended timelines |
Why buy PT-141 as a 10-pack
Single-vial retail pricing punishes people who actually use volume. Our 10-pack format works out to $35.00 per vial — up to 30% below typical single-vial retail in Canada — and because every vial ships from one production lot, a single certificate of analysis covers your entire supply. One order, one batch, zero between-vial variance.
Quality & testing
Every lot is independently tested for identity (mass spectrometry) and purity (HPLC) before release. Packs ship cold-packed with tracking from our Canadian facility, and each order automatically includes one free vial of bacteriostatic water.
Reviews
There are no reviews yet.